National Donor Deferral Registry (NDDR) Helps Ensure That Deferred Donors Cannot Donate Their Plasma Again
The National Donor Deferral Registry (NDDR) is a database of permanently deferred source plasma donors in North America. It is one of many voluntary, self-regulating initiatives taken by the source plasma collection industry and is an important component of the industry-driven safety measures that help ensure the safety of the final therapies.
All donors who test "reactive" for the viral agents for HIV, HBV and HCV are added to the NDDR and are permanently prohibited from donating source plasma at participating licensed and industry-certified centers in the U.S. and Canada.
The NDDR first was made available to all blood and source plasma facilities in December 1993. Haemonetics, a valued partner of PPTA, is responsible for the administration and customer support services of the NDDR.
All inquires should be directed to the NDDR Customer Support Desk at 1-877-534-3578.
PPTA Remembers Corey Dubin +
The Plasma Protein Therapeutics Association (PPTA) notes with sadness the passing of Corey Dubin, President Emeritus of the Committee of Ten Thousand and longtime advocate in the hemophilia community.Read More
Registration now open for the 2017 International Plasma Protein Congress! +
PPTA Chosen to Join Mission to China +
On Oct. 16-21, the Chairman of the PPTA Global Board of Directors and the PPTA President & CEO will be joining U.S. Department of Commerce-led Healthcare Business Development Mission to China.Read More
PPTA Standards Programs